Kamakura, Japan

Mizuki Okuyama

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mizuki Okuyama. Retrieved from https://idiyas.com/inventor/mizuki-okuyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mizuki Okuyama: Innovator in Nitrogen-Containing Heterocyclic Compounds

Introduction

Mizuki Okuyama is a prominent inventor based in Kamakura, Japan. She has made significant contributions to the field of chemistry, particularly in the development of low-molecular compounds with the ability to activate Nrf2, a crucial protein in cellular defense mechanisms.

Latest Patents

Mizuki Okuyama holds 1 patent for her invention titled "Nitrogen-containing heterocyclic compound having NRF2 activation effect." This patent describes a compound or its salts and solvates that can activate Nrf2. The invention includes a compound represented by a specific formula, where various components are selected from groups including hydrogen, halogen, and C-Calkoxy, among others.

Career Highlights

Mizuki Okuyama is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work focuses on innovative solutions in drug development, particularly in the area of compounds that can enhance cellular protection.

Collaborations

Mizuki collaborates with notable colleagues such as Atsushi Kimbara and Takeo Harada. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Mizuki Okuyama's contributions to the field of chemistry and her innovative patent on nitrogen-containing heterocyclic compounds highlight her role as a significant inventor. Her work continues to impact the scientific community and the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…